MediPharm Labs Corp. LABS.TO
Nov 4, 2026, 1:25 PM EST
- YTD
- 0.00%
- 1 year
- -7.14%
- Market cap
- 27.77M
- Revenue (ttm)
- 37.76M
- Profit margin
- -35.25%
- EPS (ttm)
- -0.01
- Shares out
- 411.12M
- Forward P/E
- -6.00
- YTD return
- 0.00%
- 1-year return
- -7.14%
- Volume
- 39.83K
- Avg volume
- 125.67K
- Open
- 0.065
- Previous close
- 0.06
- Day's range
- 0.06 – 0.065
- 52-week range
- 0.06 – 0.10
- Beta
- 0.92
2Y -0.0050 (-7.14%)
Key statistics
- Enterprise value
- 15.12M
- PEG ratio
- 0.00
- Price / sales
- 0.65
- Price / book
- 0.45
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 8.00%
- Free cash flow
- 7.26M
- Total cash
- 16.47M
- Total debt
- 2.81M
- Return on equity
- -24.96%
- Short % of float
- 0.00%
- 50-day average
- 0.0696
- 200-day average
- 0.07265
Analyst view
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
About MediPharm Labs Corp.
MediPharm Labs Corp., a pharmaceutical company, engages in the production and sale of purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll cannabis products. In addition, the company offers cannabis related medical information and services; and medical cannabis clinic services. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Canada
- Website
- medipharmlabs.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on LABS.TO — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Gamma Investing LLC | 0.00% | 200 | 11 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Amplify Seymour Cannabis ETF | 0.71% | 2,927,844 | 175.67K | Sep 29, 2024 |